Ads
related to: what is the fda
Search results
FDA advisors express skepticism as they debate MDMA therapy for PTSD
WLRN Miami· 15 hours agoTuesday, scientific advisors to the Food and Drug Administration are deciding whether to recommend...
FDA panel votes against ecstasy for PTSD
Axios· 9 hours agoWhy it matters: While there's a growing effort to use hallucinogenic substances as behavioral health treatments, regulators are grappling with how to...
MDMA Treatment for PTSD Gets Voted Against by FDA Advisers
TMZ· 8 hours ago4:22 PM PT -- And just like that, the FDA advisers who were mulling over using ecstasy to treat...
FDA advisers consider MDMA therapy to treat PTSD
WKOW 27 Madison· 19 hours agoIt’s the first time the FDA’s advisers have considered a psychedelic drug for medical use. The novel treatment has the potential to transform a field...
Panel recommends FDA reject MDMA as treatment for PTSD
Washington Post· 13 hours agoThe advisory committee is made up of independent mental health and medical experts, and its vote is...
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
WSB Radio· 15 hours agoThe Food and Drug Administration convened a panel of outside experts Tuesday to review the latest...
FDA sets panel review for IceCure's breast cancer treatment By Investing.com
Investing.com· 15 hours agoThe U.S. Food and Drug Administration (FDA) is set to convene a Medical Device Advisory Committee...
FDA vaccine advisors expected to vote on new COVID-19 booster formula
ABC Action News Tampa Bay· 18 hours agoThe FDA’s vaccine advisory committee is expected to meet Tuesday. It was postponed due to the...
FDA advisory panel votes against allowing MDMA as PTSD treatment
UPI· 6 hours agoThe popular underground drug midomafetamine, also called MDMA and "ecstasy," failed to win an...
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
Medical Xpress· 14 hours agoThe Food and Drug Administration convened a panel of outside experts Tuesday to review the latest...